Abstract
Instrumentation executives are by nature an optimistic lot. This year, leaders attending the Pittcon scientific instrumentation conference in sunny Orlando had more reasons than usual to be optimistic. As Pittcon got under way at the end of February, the economy, both in the U.S. and globally, was gaining momentum. Increases in academic and business investment, especially in the life sciences, had already translated into strong instrument sales in 2017 for instrument makers such as Thermo Fisher Scientific, Waters Corp., Bruker, and Shimadzu. Executives from those firms said the trend should continue, and even accelerate, in 2018. At Pittcon in Chicago last year, instrumentation executives were wary of U.S. tax reform and the changes it could bring to the way they operate. Now that the law is in place, though, executives expect they will benefit from lower tax rates and new rules allowing them to move profits banked offshore back to
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.